Rxl max
The RxL Max is a versatile lab equipment product offered by Siemens. It is designed to perform a range of laboratory tasks. The specific core function of the RxL Max is to provide accurate and reliable analytical capabilities for various applications. Further details on the intended use of this product are not available.
Lab products found in correlation
8 protocols using rxl max
Fructose Challenge and Metabolic Effects
Comprehensive Laboratory Assessments for Clinical Management
haematology: haemoglobin, haematocrit, leukocytes (white blood cell), and platelets;
serum electrolytes: sodium (Na+) and potassium (K+);
renal and liver function tests: creatinine, estimated glomerular filtration rate (eGFR) by Modification of Diet in Renal Disease method was calculated,
plasma N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) (method: immunoenzymatic, Siemens, Marburg, Germany) and troponin I (method: immunoenzymatic, single Dimension RxL Max, Siemens).
Comprehensive Cardiovascular Biomarker Profiling
The Quantikine ELISA Immunoassay kit (R&D Systems, Inc., Minneapolis, MN, USA) was used to determine the levels of the remaining markers of interest. This assay employs the quantitative sandwich enzyme immunoassay technique. These were the following proteins: GDF-15 (also known as macrophage inhibitory cytokine-1 (MIC-1) (n = 79), CXL4/PF4 (Platelet Factor 4), follistatin (FS), MMP-9 (matrix metalloproteinases—gelatinase) (n = 159), lipocalin-2 (NGAL) (n = 159), myostatin (GDF-8), E-Selectin (CD62E), ICAM-1 (CD54 allele-specific), Il-6 and Il-22 (n = 159). The Synergy/HTX multi-mode reader analyzer was used for the measurement of absorbance. This research was carried out in the laboratory of the Department of Clinical Pharmacology at Wroclaw Medical University.
Serum Biomarker Profiling in Cardiac Puncture
Serum Biomarker Quantification
Thyroid and Glucose Monitoring in Pregnancy
Urine Biomarkers in Heart Failure
We designed the first, baseline, urine sample to be obtained before the first in-hospital dose of intravenous furosemide. However, if the patient was not able to provide this sample before iv furosemide, the first available sample was taken. At day-1, day-2 and at discharge the first post diuretic urine was collected. The more detailed methods regarding urine sampling and assessment were presented elsewhere [11] (link).
All patients were instructed to limit their fluid intake to 1.5-2 L per 24 h as well as they were advised to limit their daily sodium intake during hospitalization as part of routine clinical practice in our institution.
Serum Sodium and EGFR Mutation Detection
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!